Shares of Danaher Corp. DHR slipped 8.15% to $181.77 Friday, on what proved to be an all-around poor trading session for the ...

Danaher Corp. closed 29.75% below its 52-week high of $281.70, which the company achieved on August 1st.

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...

Danaher Corporation incorporates science and technology and has a market cap of $150B. Click here to read why I rate DHR ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies.

In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...

Investment analysts at Zacks Research cut their Q1 2025 earnings per share estimates for shares of Danaher in a report issued ...

Key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), BD (US), ...